Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Greetings from Beijing Genomics Institute (BGI)

    Hello everyone, I'm Daisy from Beijing Genomics Institute(BGI). I'm here to communicate with you, and to share BGI's acquisitions with you.

  • #2
    Hello Daisy831, my name is Jerry. I am about to start my work at BGI Shenzhen. It's nice to hear from you, and I hope to communicate with you about NGS and BGI...

    Comment


    • #3
      Dear Daisy831 & Jerry,

      Welcome to SEQanswers and enjoy your stay in this palace of collective wisdom.

      Our untarnishable source of pure knowledge on next-gen sequencing shall grant you the keys to open doors to unimaginable projects.


      -seb, from Canada

      Comment


      • #4
        well, hope to see in shenzhen

        Comment

        Latest Articles

        Collapse

        • seqadmin
          Addressing Off-Target Effects in CRISPR Technologies
          by seqadmin






          The first FDA-approved CRISPR-based therapy marked the transition of therapeutic gene editing from a dream to reality1. CRISPR technologies have streamlined gene editing, and CRISPR screens have become an important approach for identifying genes involved in disease processes2. This technique introduces targeted mutations across numerous genes, enabling large-scale identification of gene functions, interactions, and pathways3. Identifying the full range...
          08-27-2024, 04:44 AM
        • seqadmin
          Selecting and Optimizing mRNA Library Preparations
          by seqadmin



          Sequencing mRNA provides a snapshot of cellular activity, allowing researchers to study the dynamics of cellular processes, compare gene expression across different tissue types, and gain insights into the mechanisms of complex diseases. “mRNA’s central role in the dogma of molecular biology makes it a logical and relevant focus for transcriptomic studies,” stated Sebastian Aguilar Pierlé, Ph.D., Application Development Lead at Inorevia. “One of the major hurdles for...
          08-07-2024, 12:11 PM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by seqadmin, 08-27-2024, 04:40 AM
        0 responses
        16 views
        0 likes
        Last Post seqadmin  
        Started by seqadmin, 08-22-2024, 05:00 AM
        0 responses
        293 views
        0 likes
        Last Post seqadmin  
        Started by seqadmin, 08-21-2024, 10:49 AM
        0 responses
        135 views
        0 likes
        Last Post seqadmin  
        Started by seqadmin, 08-19-2024, 05:12 AM
        0 responses
        124 views
        0 likes
        Last Post seqadmin  
        Working...
        X